BR9800956A - Composição farmacêutica que age por inibição das serinas proteases, e, medicamento - Google Patents
Composição farmacêutica que age por inibição das serinas proteases, e, medicamentoInfo
- Publication number
- BR9800956A BR9800956A BR9800956-7A BR9800956A BR9800956A BR 9800956 A BR9800956 A BR 9800956A BR 9800956 A BR9800956 A BR 9800956A BR 9800956 A BR9800956 A BR 9800956A
- Authority
- BR
- Brazil
- Prior art keywords
- acts
- pharmaceutical composition
- equal
- serine proteases
- medicine
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 102000012479 Serine Proteases Human genes 0.000 title abstract 2
- 108010022999 Serine Proteases Proteins 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- -1 AND Substances 0.000 abstract 1
- 101100439662 Arabidopsis thaliana CHR5 gene Proteins 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 150000001735 carboxylic acids Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003355 serines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
- C07F9/4012—Esters of acyclic acids which can have further substituents on alkyl substituted by B, Si, P or a metal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"COMPOSIçãO FARMACêUTICA QUE AGE POR INIBIçãO DAS SERINAS PROTEASES, E, MEDICAMENTO" Composições farmacêuticas que agem por inibição das serinas proteases, caracterizadas pelo fato de que compreendem, em associação com qualquer excipiente apropriado, pelo menos um composto de fórmula geral (I) seguinte: R~ 6~R~ 7~P~ (O) - (CHR5)~ m~ - (CHR4)~ n~ - Si (OR~ 1~) (OR~ 2~) (R~ 3~) (I) na qual R~ 1~ e R~ 2~ cada um independentemente representam um átomo de hidrogênio ou um grupamento alquila, R~ 3~ representa um grupamento hidroxila, ou um grupamento alcoxi ou um grupamento alquila, R~ 4~ e R~ 5~ representam, cada um independentemente, um átomo de hidrogênio, um grupamento hidroxila, um grupamento alquila ou uma função de ácido carboxílica, R~ 6~ e R~ 7~ representa, cada um independentemente um grupamento alcoxi, n é um inteiro superior ou igual a 0 e inferior ou igual a 4, m é um inteiro estritamente superior a 0 e inferior ou igual a 3.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9703793A FR2761075B1 (fr) | 1997-03-24 | 1997-03-24 | Nouveaux composes a base de silicium biologiquement actifs et leurs applications therapeutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9800956A true BR9800956A (pt) | 2001-03-13 |
Family
ID=9505261
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI9800956A BRPI9800956B8 (pt) | 1997-03-24 | 1998-03-24 | composição terapêutica que age por inibição das serinas proteases |
| BR9800956-7A BR9800956A (pt) | 1997-03-24 | 1998-03-24 | Composição farmacêutica que age por inibição das serinas proteases, e, medicamento |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI9800956A BRPI9800956B8 (pt) | 1997-03-24 | 1998-03-24 | composição terapêutica que age por inibição das serinas proteases |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6001389A (pt) |
| EP (1) | EP0870504B1 (pt) |
| JP (1) | JPH10279484A (pt) |
| AR (1) | AR011998A1 (pt) |
| AT (1) | ATE290538T1 (pt) |
| BR (2) | BRPI9800956B8 (pt) |
| CA (1) | CA2234500C (pt) |
| DE (1) | DE69829236T2 (pt) |
| DK (1) | DK0870504T3 (pt) |
| ES (1) | ES2239384T3 (pt) |
| FR (1) | FR2761075B1 (pt) |
| PT (1) | PT870504E (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2799758B1 (fr) | 1999-10-15 | 2002-05-17 | Exsymol Sa | Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation |
| CA2456025C (en) * | 2001-08-29 | 2011-11-22 | Ricardo A.P. De Carvalho | An implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| EP1583765A4 (en) * | 2002-11-18 | 2008-03-26 | Grenpharma Llc | COMPOSITIONS FOR THE TREATMENT AND / OR PREVENTION OF DISEASES CHARACTERIZED BY THE PRESENCE OF METALLIC IONS |
| US7595308B2 (en) | 2002-11-18 | 2009-09-29 | Grenpharma Llc | Compositions for treating and/or preventing diseases characterized by the presence of metal ions |
| EP1812013A1 (en) * | 2004-10-22 | 2007-08-01 | Grenpharma LLC | Compositions for treating and/or preventing diseases characterized by the presence of the metal ions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1090210B (de) * | 1956-05-31 | 1960-10-06 | Gen Electric | Verfahren zur Herstellung von Phosphonsaeureesterreste enthaltenden Organosiliciumverbindungen |
| FR6871M (pt) * | 1966-12-23 | 1969-04-14 | ||
| US3914416A (en) * | 1966-12-23 | 1975-10-21 | Exsymol Sa | Certain monomethyl trisilanol mannuronate complexes for treating cellulitis |
| FR2610522B1 (fr) * | 1987-02-06 | 1989-08-18 | Gueyne Jean | Produit therapeutique a base de derives organiques du silicium |
| JPH0532683A (ja) * | 1991-07-29 | 1993-02-09 | Sanwa Kagaku Kenkyusho Co Ltd | 有機ゲルマニウム並びに有機珪素化合物、その製法及び用途 |
| FR2725208B1 (fr) * | 1994-09-30 | 1996-11-29 | Exsymol Sa | Procede de preparation de composes de silicium biologiquement actifs sous forme concentree |
| FR2725207B1 (fr) * | 1994-09-30 | 1996-11-29 | Exsymol Sa | Composes a base de silicium biologiquement actifs, leurs applications therapeutiques et cosmetiques |
-
1997
- 1997-03-24 FR FR9703793A patent/FR2761075B1/fr not_active Expired - Fee Related
-
1998
- 1998-03-18 CA CA002234500A patent/CA2234500C/fr not_active Expired - Fee Related
- 1998-03-19 JP JP10070367A patent/JPH10279484A/ja active Pending
- 1998-03-23 AR ARP980101309A patent/AR011998A1/es not_active Application Discontinuation
- 1998-03-23 EP EP98480017A patent/EP0870504B1/fr not_active Expired - Lifetime
- 1998-03-23 PT PT98480017T patent/PT870504E/pt unknown
- 1998-03-23 DE DE69829236T patent/DE69829236T2/de not_active Expired - Fee Related
- 1998-03-23 ES ES98480017T patent/ES2239384T3/es not_active Expired - Lifetime
- 1998-03-23 DK DK98480017T patent/DK0870504T3/da active
- 1998-03-23 AT AT98480017T patent/ATE290538T1/de active
- 1998-03-24 US US09/046,511 patent/US6001389A/en not_active Expired - Lifetime
- 1998-03-24 BR BRPI9800956A patent/BRPI9800956B8/pt unknown
- 1998-03-24 BR BR9800956-7A patent/BR9800956A/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0870504A2 (fr) | 1998-10-14 |
| ATE290538T1 (de) | 2005-03-15 |
| EP0870504B1 (fr) | 2005-03-09 |
| JPH10279484A (ja) | 1998-10-20 |
| CA2234500A1 (fr) | 1998-09-24 |
| PT870504E (pt) | 2005-07-29 |
| ES2239384T3 (es) | 2005-09-16 |
| US6001389A (en) | 1999-12-14 |
| DK0870504T3 (da) | 2005-07-18 |
| DE69829236D1 (de) | 2005-04-14 |
| EP0870504A3 (fr) | 2002-09-11 |
| BRPI9800956B8 (pt) | 2021-05-25 |
| CA2234500C (fr) | 2009-08-25 |
| FR2761075B1 (fr) | 1999-06-11 |
| BRPI9800956B1 (pt) | 2018-09-11 |
| FR2761075A1 (fr) | 1998-09-25 |
| AR011998A1 (es) | 2000-09-13 |
| DE69829236T2 (de) | 2006-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0114253A (pt) | Antagonistas de receptor de glutamato metabotrópico | |
| DK0941218T3 (da) | Antithrombotiske organiske nitrater | |
| BR9707064A (pt) | Novos derivados 19-nor-pregneno | |
| FR2708608A1 (fr) | Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant. | |
| FR2708605A1 (fr) | Dérivés du N-sulfonylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. | |
| FR2708606A1 (fr) | Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. | |
| BR9406129A (pt) | Composição endurecível para um revestimento resistente a abrasão processo para sua preparacão e produtos e artigos obtidos | |
| WO2003082798A8 (es) | Compuestos naturales y derivados de éstos para la prevención y el tratamiento de enfermedades cardiovasculares, hepáticas, renales y para aplicaciones cosméticas | |
| GR3001405T3 (en) | Pyrrolidineamide derivative having anti-prolyl endopeptidase activity, compositions comprising the same, processes for the preparation of the same, and the use of the same for the preparation of a medicament of therapeutic value | |
| BR9810163A (pt) | Compostos ou suas composições | |
| BR9911300A (pt) | Composto, composição farmacêutica, e, uso do composto | |
| IL136100A (en) | Biphenylamidine derivatives and pharmaceutical compositions containing the same | |
| ATE114465T1 (de) | Pharmazeutische zusammensetzung zur inhibierung der knochenresorption. | |
| BR9916845A (pt) | Compostos de (aminoiminometil ouaminometil)benzo-heteroarila substituìdos | |
| BR9800956A (pt) | Composição farmacêutica que age por inibição das serinas proteases, e, medicamento | |
| BR9909086A (pt) | Derivados de piperidinila e n-amidinopiperidinila | |
| NZ505614A (en) | Pentasaccharides and pharmaceutical compositions thereof, useful as anti blood clotting agnets | |
| NZ230128A (en) | Dibenzooxepine-pyridinium and -pyrrolo derivatives and pharmaceutical compositions | |
| BR9912817A (pt) | Composição terapêutica à base de isoflavonóides destinada a ser utilizada no tratamento dos tumores por agentes citotóxicos | |
| DK0441467T3 (da) | Sidekædehomologe vitamin D-derivater, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemiddel | |
| CA2225780A1 (fr) | Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| GR3022761T3 (en) | Novel benzopyran derivatives and processes for the preparation thereof | |
| BR0112338A (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BR9800936A (pt) | Composto organo-silicado e composição terapêutica ou cosmética. | |
| UA41340C2 (uk) | Похідні циклогексанкарбонової кислоти, суміш їх ізомерів або окремі ізомери і фізіологічно прийнятні солі і фармацевтична композиція з активністю, що гальмує ферментний комплекс глюкоза-6-фосфатази |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART. 37, INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ART. 8O COMBINADO COM O ART. 13 DA LPI 9279/96). |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 16A ANUIDADE. |
|
| B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO DE EXIGENCIA 6.6 POR TER SIDO INDEVIDA RRF. RPI 2318 |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/09/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/03/1998 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 24/03/2018 |